XTI Aerospace insider grant: 2.62M options to CEO Pomeroy
Rhea-AI Filing Summary
Scott Pomeroy, identified as Director and Chief Executive Officer of XTI Aerospace, Inc. (XTIA), acquired 2,621,100 stock options on 09/04/2025. The filing shows the award as an acquisition of derivative securities under the companys Amended and Restated 2018 Employee Stock Incentive Plan. One-third of the options vested on the grant date and the remainder vests in equal quarterly installments over two years. The options reference an exercise price of $2 and an expiration date of 09/04/2035. The filing is signed by an attorney-in-fact on behalf of Mr. Pomeroy.
Positive
- Options granted under the companys Amended and Restated 2018 Employee Stock Incentive Plan, indicating a pre-established compensation framework.
- One-third of the options vested on the grant date, providing immediate alignment between the CEO and shareholders.
Negative
- Large option award of 2,621,100 shares could be dilutive depending on the companys outstanding share count (outstanding shares not disclosed in this filing).
- Filing lacks contextual metrics such as total outstanding shares, grant valuation, or percentage of ownership change, limiting assessment of materiality.
Insights
TL;DR: A CEO/director option grant of 2.62M shares was recorded with partial immediate vesting under the company's 2018 incentive plan.
The Form 4 documents a sizeable equity award to the reporting person who serves as both Director and CEO, with one-third vesting immediately and the remainder vesting quarterly over two years. The options carry an exercise-price reference of $2 and an expiration in 2035, and they were granted under the issuers Amended and Restated 2018 Employee Stock Incentive Plan. This is a standard disclosure of insider compensation activity required under Section 16; the filing itself does not include additional context such as total outstanding shares or potential dilution percentages.
TL;DR: The award structure mixes immediate and time-based vesting, aligning short-term and multi-year retention incentives.
The option grant shows a typical mix of immediate vesting (one-third) and continued vesting over two years, which combines immediate reward with retention-based incentives. The instrument is a stock option with an exercise-price reference of $2 and an expiration date of 09/04/2035. The Form 4 notes the grant was made under the companys 2018 plan. The filing does not disclose grant valuation, accounting treatment, or the impact on outstanding share count.